67
Participants
Start Date
July 10, 2023
Primary Completion Date
July 31, 2026
Study Completion Date
July 31, 2026
REC-4881
REC-4881 4mg capsules
Placebo
Placebo capsules
RECRUITING
University of Pennsylvania, Philadelphia
ACTIVE_NOT_RECRUITING
Digestive and Liver Center of Florida, Orlando
WITHDRAWN
GI Pros, Naples
RECRUITING
Vanderbilt Digestive Center, Nashville
ACTIVE_NOT_RECRUITING
Gastro One-8110 Walnut Rs, Cordova
WITHDRAWN
Gastroenterology Health Partners, PLLC, New Albany
RECRUITING
Corewell Health (Spectrum Health Hospitals Colorectal Cancer Multis), Grand Rapids
RECRUITING
Mayo Clinic - Rochester, Rochester
RECRUITING
Washington University School of Medicine, St Louis
TERMINATED
Tandem Clinical Research, Marrero
RECRUITING
Genetic Cancer Prevention Clinic - UT Southwestern, Dallas
RECRUITING
MD Anderson Cancer Center, Houston
RECRUITING
Huntsman Cancer Institute and University of Utah, Salt Lake City
ACTIVE_NOT_RECRUITING
Mayo Clinic - Scottsdale, Scottsdale
WITHDRAWN
Del Sol Research Management, Tucson
WITHDRAWN
Medical Associates Research Group, San Diego
RECRUITING
Benaroya Research Institute at Virginia Mason, Seattle
Recursion Pharmaceuticals Inc.
INDUSTRY